These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
271 related items for PubMed ID: 29849018
1. A Case of Right-Sided Ulcerative Colitis with Mesalamine-Induced Hypersensitivity Reactions. Hirono H, Watanabe K, Hasegawa K, Honma T, Ajioka Y, Ohkoshi S. Am J Case Rep; 2018 May 31; 19():623-629. PubMed ID: 29849018 [Abstract] [Full Text] [Related]
2. Crohn's Disease with Mesalazine Allergy that Was Difficult to Differentiate from Comorbid Ulcerative Colitis. Tsuboi R, Matsumoto S, Miyatani H, Mashima H. Intern Med; 2019 Mar 01; 58(5):649-654. PubMed ID: 30333413 [Abstract] [Full Text] [Related]
3. Ulcerative colitis occurring in the course of rheumatoid arthritis: a case successfully treated with mesalamine enema. Sugisaki K, Honma F, Iwadate H, Shio K, Shioya Y, Fukaya E, Sato K, Saito H, Sekine H, Kobayashi H, Orikasa H, Watanabe H, Sato Y. Intern Med; 2004 Nov 01; 43(11):1046-50. PubMed ID: 15609700 [Abstract] [Full Text] [Related]
4. Ulcerative colitis flair induced by mesalamine suppositories hypersensitivity. Ding H, Liu XC, Mei Q, Xu JM, Hu XY, Hu J. World J Gastroenterol; 2014 Apr 07; 20(13):3716-8. PubMed ID: 24707159 [Abstract] [Full Text] [Related]
6. Effect of Long-Term Mesalamine Therapy on Cancer-Associated Gene Expression in Colonic Mucosa of Patients with Ulcerative Colitis. Bajpai M, Seril DN, Van Gurp J, Geng X, Alvarez J, Minacapelli CD, Gorin S, Das KK, Poplin E, Cheng J, Amenta PS, Das KM. Dig Dis Sci; 2019 Mar 07; 64(3):740-750. PubMed ID: 30478770 [Abstract] [Full Text] [Related]
7. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease. Matsuda R, Koide T, Tokoro C, Yamamoto T, Godai T, Morohashi T, Fujita Y, Takahashi D, Kawana I, Suzuki S, Umemura S. Inflamm Bowel Dis; 2009 Mar 07; 15(3):328-34. PubMed ID: 18942752 [Abstract] [Full Text] [Related]
8. Mesalamine treatment mimicking relapse in a child with ulcerative colitis. Hojsak I, Pavić AM, Kolaček S. World J Pediatr; 2014 Nov 07; 10(4):371-3. PubMed ID: 24974209 [Abstract] [Full Text] [Related]
17. Fecal microbiota transplantation treatment for refractory ulcerative colitis with allergy to 5-aminosalicylic acid: A case report. Wang HG, Liu SP, Ma TH, Yan W, Zhou JF, Shi YT, Shen P, Yang XZ, Wu SN. Medicine (Baltimore); 2018 May 07; 97(19):e0675. PubMed ID: 29742710 [Abstract] [Full Text] [Related]
18. Encapsulated mesalamine granules (Apriso) for ulcerative colitis. Med Lett Drugs Ther; 2009 May 18; 51(1312):38-9. PubMed ID: 19448588 [Abstract] [Full Text] [Related]
19. Oral mesalamine and clinical remission are associated with a decrease in the extent of long-standing ulcerative colitis. Picco MF, Krishna M, Cangemi JR, Shelton D. Inflamm Bowel Dis; 2006 Jul 18; 12(7):537-42. PubMed ID: 16804389 [Abstract] [Full Text] [Related]
20. Mesalamine-induced myopericarditis - A case report. Bernardo S, Fernandes SR, Araújo-Correia L. Rev Esp Enferm Dig; 2016 Nov 18; 108(11):753-756. PubMed ID: 26876057 [Abstract] [Full Text] [Related] Page: [Next] [New Search]